Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Health US Lab Receives CLIA Certification

NEW YORK (GenomeWeb News) – Molecular Health today announced its US clinical laboratory has been CLIA-certified.

With the certification, the Woodlands, Texas-based facility will begin offering two tests. One is a targeted gene panel of more than 500 known cancer genes, and the other offers whole-exome sequencing of the tumor genome.

"Now that our certification is complete, we'll soon be able to begin receiving and analyzing samples in order to provide oncologists and pathologists with personalized information on their patients' tumors," Molecular Health Chief Medical Officer Shelly Gunn said in a statement.

Molecular Health announced the opening of its office in The Woodlands in January. The company was originally founded in Basel, Switzerland and its headquarters are now in Germany. The US office and lab occupies about 7,000-square-feet of space. The lab is being equipped with Illumina sequencers.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.